Spin-off extends HIS firm’s Web portal plansQuadraMed, a provider of health information systems and Web-based data management software, plans to leverage its expertise in online healthcare and its
Spin-off extends HIS firms Web portal plans
QuadraMed, a provider of health information systems and Web-based data management software, plans to leverage its expertise in online healthcare and its installed customer base with a new subsidiary and a unique approach to online medical records designed to be less disruptive to existing physician workflow patterns. The San Rafael, CA-based company recently formed ChartOne.com, a spin-off that will capture patient charts at the point of completion and provide record retrieval and storage services via the Internet.
ChartOne, headquartered in San Jose, CA, will offer an as-yet- unnamed product that will electronically capture paper records through digital imaging and data feeds. The records will then be stored online and made accessible using standard Web browsers on standard PCs. By imaging paper records at the point of completion and then making them electronically available, ChartOne expects to provide a more efficient, cost-effective way to capture, store, and manage patient records with less workflow disruption than current imaging or storage alternatives.
We all know that electronic patient records will be the ideal solution, but the fact is this has been discussed for at least 15 years and we dont see any near-term change in lack of adoption, said Jim Durham, chairman and CEO of QuadraMed. Since meaningful use of online medical record systems has failed to materialize, we believe that the ideal solution for now is to scan the patient record and then offer Internet-based imaging, storage, and access.
ChartOne is already beginning to market its flagship product, which will likely operate via an application service provider model. The archiving component, which is still undergoing beta testing, is being handled through QuadraMeds existing data centers at the moment, but the company expects that once volumes increase they will likely offload this service to another archiving vendor.
In addition to establishing ChartOne, QuadraMed is looking to form strategic partnerships and joint ventures to further its overall strategy of linking integrated delivery networks and hospitals to their various constituents using Web-enabled products and services. The company handles more than five million medical records annually in 40 states and claims to have products in more than 4000 provider sites.
ChartOne represents an extension of our strategy to become a Web portal for hospitals by linking multiple constituents, including physicians, patients, insurers, and government agencies, Durham said. One of our problems as a company is that we have a lot of Internet initiatives, but we are not viewed as an Internet company.
QuadraMed is hoping that its new subsidiary and workflow products will bolster its bottom line as well. The company reported a net loss of $12.3 million on revenue of $239 million for 1999 (end-December). This compares to a net loss of $19 million on revenue of $210 million in 1998.
© 2000 Miller Freeman, Inc., a United News & Media company.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Study: Abbreviated Breast MRI Offers Equivalent Accuracy to mpMRI for Women with Dense Breasts
May 20th 2025Emerging research suggests that abbreviated breast MRI offers comparable sensitivity and specificity as multiparametric MRI in women with extremely dense breasts with a nearly 50 percent reduction in reading time for radiologists.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.